- Achillion Pharmaceuticals, Inc. stock price today and history
Achillion Pharmaceuticals, Inc. (ACHN) stock prices updated...
Please, Signup (Login) to subscribe or trade (demo)
Achillion Pharmaceuticals, Inc. stock price
Achillion Pharmaceuticals, Inc. latest news:
Here's Why Achillion Pharmaceuticals Is Soaring 19.5% Today
The company's story is finally untied from its failed relationship with Johnson & Johnson.
BRIEF-Achillion announces pricing of secondary offering of common stock
Achillion Pharmaceuticals Inc(ACHN). * Achillion announces pricing of secondary offering of common stock. * Says secondary public offering of 18.4 million common shares priced at $2.75per share Source text for Eikon: Further company coverage:
Achillion shares drop as J&J to sell large stake
Achillion Pharmaceuticals Inc. shares fell in the extended session Tuesday after the drug developer reported promising early data on one of its kidney-disease treatments but said a large stakeholder was selling shares in a secondary offering. Achillion shares fell 9.2% to $3.35 after hours. Achillion said Johnson & Johnson Inc.'s venture capital arm, Johnson & Johnson Innovation-JJDC Inc., will sell 18.4 million shares of Achillion in a public offering and that Achillion would not receive proceeds. Achillion has 136.9 million shares outstanding. Separately, the company said early data from its mid-stage clinical trial for ACH-4471 showed the drug reduced protein in the urine by more than 50% in patients with C3 glomerulopathy, a rare disease where protein deposits build up in the kidneys.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
ACI Worldwide, Inc.ACIW
Acorda Therapeutics, Inc.ACOR
Actions Semiconductor Co., Ltd.ACTS
Active Power, Inc.ACPW
Activision Blizzard, IncATVI
Acura Pharmaceuticals, Inc.ACUR
Adamas Pharmaceuticals, Inc.ADMS